Market Place
Sourcing Support
Journal of Clinical Psychiatry Publishes Data from Alkermes` ALPINE Study
20 May 2020 //
PRNEWSWIRE
Alkermes Announces Expansion of Patient Services & Network for ARISTADA®
11 May 2020 //
PR NEWSWIRE
Alkermes says long-acting drugs help schizophrenics stay on medication longer
10 Apr 2019 //
REUTERS
Longtime Alkermes executive Elliot Ehrich joins Expansion Therapeutics
13 Nov 2018 //
FIERCE BIOTECH
Alkermes` injectable schizophrenia drug, Aristada Initio gets US FDA approval
04 Jul 2018 //
PHARMABIZ
FDA Approves ARISTADA INITIO for the Initiation of ARISTADA for Schizophrenia
02 Jul 2018 //
PRESS RELEASE
Alkermes to Present Data on Depression and Schizophrenia Portfolios
23 May 2018 //
PRESS RELEASE
Alkermes’ NDA for Investigational Product Designed for Initiation Onto ARISTADA®
16 Nov 2017 //
BUSINESSWIRE
Alkermes to Initiate New Clinical Study Evaluating ARISTADA® & INVEGA SUSTENNA®
26 Oct 2017 //
BUSINESSWIRE
Alkermes Stock Climbs on Positive Test Results for Antidepressant
21 Oct 2016 //
BOSTON GLOBE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.